Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 follow
Purity:
99.97
CAS Number:
[2423943-37-5]
Target:
SARS-CoV
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
